Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Herantis Pharma: Invitation to a virtual company presentation on May 19, 2022

Herantis Pharma Plc, Press release, 12 May 2022 at 11:00 EEST   THE INFORMATION CONTAINED IN THIS RELEASE IS NOT FOR PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, CANADA, HONG KONG, JAPAN, SINGAPORE, SOUTH AFRICA OR THE UNITED STATES OR IN ANY OTHER JURISDICTION IN WHICH PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL.   Herantis Pharma Plc ("Herantis" or the "Company"), an innovative biotech company developing new disease modifying therapies for Parkinson's disease, announced today that it will host a virtual company presentation on May 19, 2022, at

Bioretec enters into a distribution agreement with AMI Medical Technologies for bioresorbable Activa products in Israel

Bioretec Ltd                                  Press Release                              12 May 2022 at 10.30 a.m. EESTBioretec Ltd, a globally operating Finnish medical device company and a pioneer in bioresorbable orthopedic implants, has entered into a distribution agreement with AMI Medical Technologies Ltd, a leading distributor of medical devices in Israel. Under the 5-year exclusive agreement, AMI Medical Technologies will distribute, promote and sell Bioretec’s bioresorbable Activa implants in Israel. Bioretec’s Activa portfolio, already sold in about 40 countries, consists of

Press release from annual general meeting in Azelio AB (publ) on 12 May 2022

At the annual general meeting in Azelio AB (publ) the shareholders resolved upon the following:   Approval of the financial statements of 2021 and discharge from liability The annual general meeting approved the income statement and balance sheet as well as the consolidated income statement and the consolidated balance sheet for the financial year 2021, and the members of the board and the managing director was discharged from liability for the financial year 2021.   Allocation of profit or loss  The annual general meeting resolved, in accordance with the board’s proposal,

IT services giant Centric selects IFS Cloud and Eqeep to centralize operations and drive growth across Europe

London, UK,  May 12, 2022 – IFS , the global cloud enterprise software company, today announced that multinational IT services company, Centric  has selected IFS Cloud™   to advance its digital transformation and centralise its IT environment. IFS solution partner Eqeep , will implement and support the solution and roll it out across Centric’s entire operations, encompassing sites across ten European countries. Following a competitive tender process, Centric chose

KONE to equip a new hospital in North Zealand in Denmark

KONE Corporation, press release, May 12, 2022    KONE Corporation, a global leader in the elevator and escalator industry, has won an order to supply a suite of People Flow® solutions, including 40 KONE elevators, for a new hospital in North Zealand area.  This new hospital will become an integral part of the business and residential area of Favrholm on Overdrevsvejen south of Hillerød in capital region. It is expected that the hospital will receive and treat around 500,000 patients annually.   KONE's delivery includes 12 KONE MonoSpace® 700 DX elevators and 28 KONE

DanCann Pharma A/S signs Letter of Intent with Aureum Pharma AB for exclusive rights with a minimum commitment of SEK 37 million

COPENHAGEN, Denmark, 12 May 2022 - DanCann Pharma A/S (SS: DANCAN) ("DanCann Pharma" or the “Company”), a Danish company powered by cannabinoids, hereby announce that the Company has signed Letter of Intent with Aureum Pharma AB (“Aureum Pharma”) for exclusive rights over its products in Sweden.DanCann Pharma is a highly experienced manufacturer of medical cannabis products in Denmark. Aureum Pharma is an entity permitted per Swedish law to import and distribute medical cannabis products. DanCann Pharma and Aureum Pharma aims to enter into a binding supply and distribution agreement

Paulig’s property in Vuosaari achieved its energy efficiency targets four years ahead of time

Paulig has achieved the energy efficiency targets with the Vuosaari property four years ahead of time. The targets are based on the energy efficiency agreement of Finland’s governmental sustainable development company Motiva. The Vuosaari property houses the head office of Paulig, and a coffee roastery where 100 million coffee packages and over 200 different products are produced annually. The coffee roastery has been carbon neutral since 2020, and the property’s unique waste heat recovery project was awarded in the Energy Genius of the Year 2020 competition. Paulig’s energy

Qlife’s new filtration unit significantly broadens the market for the Egoo platform

Qlife has developed a new, small, and disposable filtration unit able to filtrate plasma from whole blood. The filtration unit, EgooCollect, will be an integral feature of the Egoo platform making it more versatile and ideal for decentralized settings. A patent application for EgooCollect has recently been filed. The next step is to incorporate EgooCollect in the development of the PKU test in accordance with IVDR.Qlife’s scientific team has completed the development of a blood-to-plasma filtration unit for blood-based biomarker testing. The Egoo capsule already integrates all reagents and

Food waste startup, Motatos, bulks up its senior team ahead of UK launch

Motatos hires House of Fraser executive Christabel Biella to take its sustainable food delivery offering to British consumersSwedish-born grocery retailer, Motatos, has hired Christabel Biella as UK Country Manager as it sets its sights on a launch next month.  Biella brings a decade of UK retail experience to the table, with previous roles including merchandising and purchasing roles at House Of Fraser, luxury furniture brand Swoon, and high street fashion chain TK Maxx. As Country Manager, Biella will be responsible for building the brand and initiating partnerships with retailers

New Business Update - Ayima Group AB

Further to the previous update of Feb 11, 2022, Ayima is pleased to announce some significant new business wins and an update on the general business situation After a difficult period in March and April, the new business situation has returned to normal in May. Since the begining of the month, Ayima has signed agreements with 9 new clients for an approximate total of 5.75 MSEK annually. While this welcome development will not have much impact on the 2nd quarter results, it bodes well for a return to growth and profitability in Q3. Operationally, Ayima is performing well and all

Polygiene’s aim is set for full coverage odor control in Forloh hunting apparel

Leading-edge technology makes Forloh's new Insect Shield® apparel best in class for warm weather adventures - combines fabric technologies and design in innovative new summer collection. The 100% made-in-America  technical outdoor brand, is proud to introduce new, lightweight Insect Shield® shirts and pants that deliver unprecedented comfort and protection in the most innovative garments ever designed for outdoor enthusiasts. Image: Forloh. Text based on

Cereno Scientific’s abstract on CS1’s innovative Phase II study design accepted at top pulmonary vascular congress PVRI held in June, 2022

Cereno Scientific (XSAT: CRNO B) today announced that an abstract regarding the innovative design of the Phase II study with drug candidate CS1 in pulmonary arterial hypertension (PAH) has been accepted as a poster presentation at the 15th Annual World Congress on Pulmonary Vascular Disease in Athens, Greece, on June 22-26, 2022. The abstract is a collaboration between Cereno, Dr. Raymond Benza, global PAH key opinion leader and principal investigator (PI) for the Phase II study and study collaborator Abbott.The abstract with the title “Investigation of efficacy, safety and optimal dose of

Nixu Corporation’s new shares have been registered in the Trade Register

Nixu Corporation, Stock Exchange Release, May 12, 2022 at 9:30 EESTOn February 28, 2022, Nixu Corporation announced a directed share issue to the new CEO of the company (Share Issue 1/2022). A total of 22,000 new Nixu Corporation shares subscribed for in the Share Issue 1/2022 have been registered in the Trade Register today, on May 12, 2022. Following the registration of the new shares, the total number of Nixu Corporation shares is 7,447,219. The total subscription price of the new shares, EUR 124,740.00, will be recorded in its entirety to the invested unrestricted equity of the

Odfjell SE: Approval of base prospectus and change of ISIN

The Financial Supervisory Authority of Norway has on May 11, 2022, approved Odfjell SE’s Registration Document and a Securities Note, both dated May 11, 2022.The Registration Document and Securities Note were prepared in connection with the listing on the Oslo Stock Exchange of the Odfjell SE FRN senior unsecured NOK 275,000,000 bond tap issue dated November 19, 2021 with temporary ISIN NO0011154676. The Registration Document and Securities Note are available at Odfjell.com. The bond issue with temporary ISIN NO0011154676 will be merged with the bond issue with original ISIN

Klaria Interim Report Q1 2022

Klaria Interim Report Q1 2022Summary of the Interim Report First quarter of 2022 - Net sales amounted to 0.0 MSEK (0.0 MSEK) - R&D costs for the period amounted to 17.1 MSEK (11.4 MSEK) - Profit after tax amounted to -20.3 MSEK (-16.7 MSEK) - Earnings per share for the quarter amounted to -0.37 SEK (0.32 SEK) - Cash flow from operating activities amounted to -19.8 MSEK (17.1 MSEK) - Cash and cash equivalents on the balance sheet date amounted to 23.0 MSEK (48.2 MSEK) - Equity as of March 31 amounted to 72.1 MSEK (126.3 MSEK) - Pursuant to the authorization granted

Concentric AB transfer own shares

The participants in LTI 2019 have the right to receive 99,184 shares, but as the performance-based terms have not been met, 49,592 shares will be transferred. In accordance with the terms of LTI 2019, 24,796 shares have a purchase price for the participants of SEK 114.00 and 24,796 shares have a purchase price of SEK 171.00. Under the authorisation from the annual general meeting 2022, the board of Concentric has resolved to sell a maximum of 49,592 shares on Nasdaq Stockholm. The difference between the sale price and the purchase price in the terms of LTI 2019 will be paid to the

Kent NHS trusts in the UK to modernize patient diagnostics with Sectra in a multi-hospital collaborative environment

Linköping, Sweden – May 12, 2022 – International medical imaging IT and cybersecurity company Sectra  (STO: SECT B) has signed a contract with Kent and Medway Medical Imaging Consortium. The new agreement will help a consortium of trusts deliver faster diagnoses, improve capacity and deliver community diagnostics. Benefits from utilizing the same imaging system as many other trusts across large of South East England are also expected.Sue Lang, who has worked as program lead for the consortium and radiology transformation program manager for East Kent Hospitals

Raisio plc: Managers´ transactions

Raisio plc Managers´ transactions 12 May 2022   MANAGERS’ TRANSACTIONS   Person subject to the notification requirement Name: Pekka Kuusniemi Position: Chief Executive Officer Issuer: Raisio Oyj LEI: 74370083282NHIP4QD02   Notification type: INITIAL NOTIFICATION Reference number: 14778/5/6 ____________________________________________   Transaction date: 2022-05-11 Venue: EUCC Instrument type: SHARE ISIN: FI0009002943 Nature of the transaction: ACQUISITION   Transaction details (1): Volume: 5911 Unit price: 1.992 EUR

3 new companies to present at the BioStock Life Science Spring Summit on June 8-9!

On June 8-9, it is finally time for BioStock Life Science Spring Summit 2022, where companies from a wide range of therapeutic areas will present their projects and innovations, in a packed program that also offers valuable insights from investment experts and industry profiles. Today, we reveal three new companies that will present at the Spring Summit!The event will be broadcasted on the BioStock website and on our YouTube channel. You can also access the event through our social media platforms. Today, we reveal three new companies that will present at the BioStock Life Science Spring

Interim Report for 1st Quarter 2022

Q1 2022 - Challenging Quarter, Improved Start of Q2 2022Key Facts for the 1[st] Quarter 2022 (1[st] January 2022 – 31[st] March 2022) All figures are compared to the same quarter last year if not explicitly stated otherwise · Revenues decreased by 41.92% to € 7,848,997 (€13,515,110). · EBIT decreased by 88.96% to € 417,239 (€3,779,057). · EBIT margin of 5.32% (27.96%). · Customer deposits decreased by 35.97% to €17,236,925 (€26,918,069).  · 74,751 new registered customers (71,709), increase of 4.24%. · 13,185 new depositing customers (29,813), decrease of 55.77%. ·

Isofol Medical AB (publ) publishes interim report, January–March 2022

GOTHENBURG, Sweden, May 12, 2022 - Isofol Medical AB (publ), (Nasdaq Stockholm: ISOFOL), announced today that the company's interim report for January–March 2022 is now available on the company's website, www.isofolmedical.com .First quarter, January–March 2022 · Net revenue amounted to TSEK 4,006 (5,215) and other revenue to TSEK 1 (0) · The result for the period amounted to TSEK -47,874 (-42,662) · Earnings per share amounted to SEK -0.30 (-0.51) · Cash and cash equivalents on March 31 amounted to TSEK 332,035 (77,524)

Intelligent instruments for optimizing mining operations: introducing Metso Outotec Sense series

Metso Outotec Corporation’s press release on May 12, 2022, at 09:00 a.m. EESTMetso Outotec has grouped its portfolio of intelligent instruments under the Sense series. The portfolio is designed to solve specific process challenges and enable optimization for minerals and hydrometallurgical processes. The market’s most comprehensive portfolio of intelligent instruments is part of Metso Outotec’s Planet Positive offering. Covering the entire flowsheet, Sense series instruments are suited for both new and existing operations. “Metso Outotec Sense series includes specialized instruments that

There are no items matching the current filter
There are no more items matching the current filter
Back to top